Coloplast Cash per Share vs. Market Capitalization

<div class='circular--portrait' style='background:#3b5998;color: #F0F8FF;font-size:4em;padding-top: 25px;;'>CO</div>
The Drivers Module shows relationships between Coloplast's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Coloplast B AS over time as well as its relative position and ranking within its peers. Check out Trending Equities.

Search Current Fundamental Trends

 
Refresh

Coloplast B AS Market Capitalization vs. Cash per Share Fundamental Analysis

Coloplast B AS is number one stock in cash per share category among related companies. It is number one stock in market capitalization category among related companies creating about  57,496,575,342  of Market Capitalization per Cash per Share.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Coloplast 
Cash per Share 
 = 
Total Cash 
Average Shares 
=
2.92 
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Coloplast 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
=
167.89 B
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Coloplast B AS is number one stock in market capitalization category among related companies. Market capitalization of Medical Instruments & Supplies industry is currently estimated at about 182.78 Billion. Coloplast totals roughly 167.89 Billion in market capitalization claiming about 92% of all equities under Medical Instruments & Supplies industry.
Capitalization  Total debt  Workforce  Revenue  Valuation

Coloplast Fundamental Comparison

Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page